Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets: 2009-2025

Historic Return on Assets for Gyre Therapeutics (GYRE) over the last 16 years, with Sep 2025 value amounting to 0.07%.

  • Gyre Therapeutics' Return on Assets rose 76.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 76.00%. This contributed to the annual value of 0.14% for FY2024, which is 100.00% up from last year.
  • As of Q3 2025, Gyre Therapeutics' Return on Assets stood at 0.07%, which was up 26.57% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Return on Assets ranged from a high of 0.43% in Q1 2023 and a low of -1.67% during Q1 2022.
  • In the last 3 years, Gyre Therapeutics' Return on Assets had a median value of -0.66% in 2024 and averaged -0.50%.
  • Over the last 5 years, Gyre Therapeutics' Return on Assets had its largest YoY gain of 210bps in 2023, and its largest YoY loss of 151bps in 2023.
  • Gyre Therapeutics' Return on Assets (Quarterly) stood at -1.31% in 2021, then spiked by 137bps to 0.06% in 2022, then tumbled by 142bps to -1.36% in 2023, then skyrocketed by 150bps to 0.13% in 2024, then skyrocketed by 76bps to 0.07% in 2025.
  • Its Return on Assets was 0.07% in Q3 2025, compared to 0.05% in Q2 2025 and 0.08% in Q1 2025.